Our CBO, Alexa Crăciunescu, joined The Medicine Maker’s IBTV Roving Reporter at ARM’s Meeting on the Med 2026 in Rome to share her perspective on what recent clinical, regulatory, and commercial breakthroughs reveal about the next phase of cell and gene therapy as well what still needs to change before transformative therapies can reach more patients worldwide.
From innovative regulatory pathways and new reimbursement models to the promise of in vivo approaches, watch Alexa and other leading voices explore where the field stands and where it’s headed: Link
